EFFICACY, SAFETY, AND TOLERABILITY OF AFQ056 FOR THE TREATMENT OF CHOREA IN PATIENTS WITH HUNTINGTON'S DISEASE

被引：0
|
作者：
Reilmann, R. [1 ,2 ]
Rouzade-Dominguez, M. [3 ]
Saft, C. [4 ]
Suessmuth, S. D. [5 ]
Priller, J. [6 ]
Rosser, A. [7 ,8 ]
Rickards, H. [9 ]
Schoels, L. [10 ]
Pezous, N. [11 ]
Gasparini, F. [12 ]
Landwehrmeyer, G. B. [5 ]
Johns, D. [13 ]
Gomez-Mancilla, B. [12 ]
机构：
[1] George Huntington Inst, D-48149 Munster, Germany
[2] Univ Munster, Dept Neurol, D-48149 Munster, Germany
[3] Novartis Pharma AG, Clin Sci & Innovat, CH-4056 Basel, Switzerland
[4] Ruhr Univ Bochum, Neurol Klin, D-44791 Bochum, Germany
[5] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany
[6] Charite, Dept Neuropsychiat, D-10117 Berlin, Germany
[7] Cardiff Univ, Sch Med, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales
[8] Cardiff Univ, Sch Biosci, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales
[9] Barberry, Dept Neuropsychiat, Birmingham B15 2FG, W Midlands, England
[10] Inst Clin Brain Res, Ctr Neurol & Hertie, Clin Neurogenet Unit, D-72076 Tubingen, Germany
[11] Novartis Pharma AG, IIS Translat Sci Early Dev Stat Res, CH-4002 Basel, Switzerland
[12] Novartis Pharma AG, Novartis Inst Biomed Res, CH-4056 Basel, Switzerland
[13] Novartis Inst Biomed Res Inc, Neurosci Translat Med, Cambridge, MA 02139 USA
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2014年 / 85卷
关键词：
D O I：
10.1136/jnnp-2014-309032.295
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
N03
引用
收藏
页码：A102 / A103
页数：3
相关论文
共 50 条
  • [41] Awareness of Chorea in Huntington's Disease
    Hergert, Danielle C.
    Sanchez-Ramos, Juan
    Cimino, Cynthia R.
    JOURNAL OF HUNTINGTONS DISEASE, 2020, 9 (01) : 99 - 103
  • [42] Efficacy and safety of risperidone in the treatment of Sydenham's chorea
    Teixeira, AL
    Maia, DP
    Cardoso, F
    MOVEMENT DISORDERS, 2005, 20 : S8 - S8
  • [43] SUBCUTANEOUS HALOPERIDOL FOR CHOREA IN PATIENTS WITH HUNTINGTON'S DISEASE AND DYSPHAGIA
    Lee, Sarah C. M.
    Jayasinghe, Indrajith
    Lie, Yenni
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A99 - A100
  • [44] Neurophysiological study of facial chorea in patients with Huntington's disease
    Muñoz, E
    Cervera, A
    Valls-Solé, J
    CLINICAL NEUROPHYSIOLOGY, 2003, 114 (07) : 1246 - 1252
  • [45] Tetrabenazine in Huntington's Disease Chorea
    Chitnis, Shilpa
    Karunapuzha, Cherian Abraham
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 669 - 681
  • [46] Deutetrabenazine for the treatment of Huntington's chorea
    Bashir, Hassaan
    Jankovic, Joseph
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (08) : 625 - 631
  • [47] Tetrabenazine Use in Patients With Huntington's Disease (HD) Chorea
    Sung, Victor W.
    Iyer, Ravi
    Schilling, Traci
    Buzinec, Paul N.
    NEUROLOGY, 2017, 88
  • [48] Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease
    Frank, S.
    Vaughan, C.
    Stamler, D.
    Oakes, D.
    Davis, M.
    Gross, N.
    Gordon, M.
    Savola, J. M.
    Wieman, M.
    Eberly, S.
    Kayson, E.
    Whaley, J.
    Goldstein, J.
    Testa, C.
    MOVEMENT DISORDERS, 2020, 35 : S98 - S98
  • [49] Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease
    Frank, Samuel
    Vaughan, Christina
    Stamler, David
    Oakes, David
    Davis, Matthew D.
    Gross, Nicholas
    Gordon, Mark Forrest
    Savola, Juha-Matti
    Wieman, Maria
    Eberly, Shirley
    Kayson, Elise
    Whaley, Jacquelyn
    Goldstein, Jody
    Testa, Claudia M.
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 26 - 27
  • [50] Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease
    Frank, Samuel
    Vaughan, Christina
    Stamler, David
    Oakes, David
    Davis, Mat D.
    Gross, Nicholas
    Gordon, Mark Forrest
    Savola, Juha-Matti
    Wieman, Maria
    Eberly, Shirley
    Kayson, Elise
    Whaley, Jacquelyn
    Goldstein, Jody
    Testa, Claudia M.
    NEUROLOGY, 2020, 94 (15)
12345